Literature DB >> 16140690

Catastrophic presentation of infant botulism may obscure or delay diagnosis.

Wendy G Mitchell1, Linda Tseng-Ong.   

Abstract

Three infants with infant botulism are presented to illustrate how atypical, early, and severe features may obscure or delay diagnosis. Two boys aged 6 weeks and 20 days, respectively, presented with rapid deterioration after brief periods of poor feeding, one with an apparent life-threatening event at home and the other with a full cardiopulmonary arrest. Initial abnormal laboratory findings of coagulopathy suggested sepsis in the first infant. In the second infant, severe acidosis and hypoglycemia suggested an underlying metabolic disorder. A third infant, aged 1 month, was hospitalized originally with an admitting diagnosis of "pharyngitis" resulting from his inability to take adequate feedings. He received intravenous fluids and antibiotics. One week later he suffered a respiratory arrest. Laboratory findings of severe hyponatremia and acidosis at the time of his arrest suggested a metabolic etiology. Even retrospectively, none of these infants had the typical initial complaint of constipation, and none were noted to have ptosis or facial weakness before catastrophic collapse. However, in each case, the parent had initially brought the child to the physician for "poor feeding" or "poor suck," which was not recognized by medical personnel as a result of bulbar weakness. Ultimately, all 3 infants were found to have infant botulism. All 3 had received antibiotics before catastrophic collapse, possibly contributing to the rapidity of the deterioration. Each recovered, although the delay in diagnosis made them ineligible for treatment with botulism immunoglobulin.

Entities:  

Mesh:

Year:  2005        PMID: 16140690     DOI: 10.1542/peds.2005-0297

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  4 in total

1.  Infant botulism.

Authors:  Eren Cagan; Erdal Peker; Murat Dogan; Huseyin Caksen
Journal:  Eurasian J Med       Date:  2010-08

2.  Antimicrobial Susceptibility of 260 Clostridium botulinum Type A, B, Ba, and Bf Strains and a Neurotoxigenic Clostridium baratii Type F Strain Isolated from California Infant Botulism Patients.

Authors:  Jason R Barash; Joe B Castles; Stephen S Arnon
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

Review 3.  Current Developments in Diagnostic Assays for Laboratory Confirmation and Investigation of Botulism.

Authors:  Dominick A Centurioni; Christina T Egan; Michael J Perry
Journal:  J Clin Microbiol       Date:  2021-09-29       Impact factor: 11.677

4.  The First Reported Case of Infant Botulism in Korea: Treatable Infantile Neuromuscular Disease.

Authors:  Hyeon Gu Jang; Jooyoung Jang; Hyun Joo Jung; Da Eun Jung
Journal:  J Korean Med Sci       Date:  2020-04-13       Impact factor: 2.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.